Compare Indonesia Kendaraan Terminal Tbk (IPCC) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesia Kendaraan Terminal Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Indonesia Kendaraan Terminal Tbk trades at Rp1,240 (market cap 2.26T, 222.6K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 5× Indonesia Kendaraan Terminal Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 222.6K). Which is the better fit depends on your goals.
| IPCC | TSPC | |
|---|---|---|
Market Cap | 2.26T | 11.36T |
Volume | 222.6K | 1.77M |
Lot | 2.23K | 17.71K |
Turnover | 275.94M | 4.61B |
Average Price | 1,239.62 | 2,603.9 |
Value | 275.94M | 4.61B |
Indicative Equilibrium Price | 1,240 | 2,590 |
Indicative Equilibrium Volume | 163 | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indonesia Kendaraan Terminal Tbk
PT Indonesia Kendaraan Terminal Tbk (“the Company”) was established based on November 05, 2012 by deed No. 10 of Yulianti Irawati SH., substitute of Nur Muhammad Dipo Nusantara Pua Upa, S.H., M.Kn., Notary in Jakarta. Prior to becoming a separate business entity, PT Indonesia Vehicle Terminal was only a strategic business unit called Tanjung Priok Car Terminal (TPT) under its Head Office and operated since June 2007.
Read more on IPCC →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
